Psoriasis and comorbid diseases: Implications for management

J Am Acad Dermatol. 2017 Mar;76(3):393-403. doi: 10.1016/j.jaad.2016.07.065.

Abstract

As summarized in the first article in this continuing medical education series, the currently available epidemiologic data suggest that psoriasis may be a risk factor for cardiometabolic disease. Emerging data also suggest associations between psoriasis and other comorbidities beyond psoriatic arthritis, including chronic kidney disease, inflammatory bowel disease, hepatic disease, certain malignancies, infections, and mood disorders. Recognizing the comorbid disease burden of psoriasis is essential for ensuring comprehensive care of patients with psoriasis. The clinical implications of the comorbid diseases that are associated with psoriasis and recommendations for clinical management are reviewed in this article.

Keywords: Crohn's disease; cardiovascular disease; chronic kidney disease; comorbidities; depression; infection; lymphoma; metabolic syndrome; nonalcoholic fatty liver disease; psoriasis; psoriatic arthritis; screening; vaccination.

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases / epidemiology*
  • Cardiovascular Diseases / prevention & control
  • Comorbidity
  • Contraindications
  • Diabetes Mellitus / diagnosis
  • Diabetes Mellitus / epidemiology
  • Dyslipidemias / epidemiology
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Infections / diagnosis*
  • Infections / epidemiology
  • Inflammatory Bowel Diseases / drug therapy
  • Inflammatory Bowel Diseases / epidemiology
  • Liver Diseases / epidemiology
  • Mood Disorders / diagnosis
  • Mood Disorders / epidemiology
  • Obesity / epidemiology
  • Obesity / therapy
  • Psoriasis / drug therapy*
  • Psoriasis / epidemiology*
  • Psoriasis / therapy
  • Renal Insufficiency, Chronic / epidemiology
  • Risk Factors
  • Skin Neoplasms / chemically induced
  • Skin Neoplasms / diagnosis*
  • Skin Neoplasms / epidemiology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha